Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-351-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The substance initiated a Stimulation Index of greater than 3 at concentrations of 5, 10 and 25 % and thus is considered to be a skin sensitizer under the conditions of the test (OECD 429 and EU Method B.42)
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24 September 2008 to 13 October 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Strain: CBA
- Source: Charles River France, L'Arbresle Cedex, France
- Age at study initiation: Young adult animals (approx. 12 weeks old)
- Housing: Individually housed in labeled Macrolon cages containing sterilized sawdust as bedding material
- Diet (e.g. ad libitum): Free access to pelleted rodent diet
- Water (e.g. ad libitum):Free access to tap water
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.5 to 23.9 C
-Humidity 43-85%
- Air changes (per hr): at least 15 changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours continuous light/dark cycle
IN-LIFE DATES: 24 September 2008 to 13 October 2008 - Vehicle:
- propylene glycol
- Concentration:
- 5%, 10%, 25%
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: the vehicle was based on trail formulations performed at Notox. Homogeneity was obtained to visually acceptable levels.
- Irritation: At a 50% test substance concentraion severe irritation of the ears was observed and therefore the highest test substance concentration selected for the main study was a 25% concentration.
- Lymph node proliferation response: Expressed as the number of radioactive disintegrations per minute per lymph nodes from each individual animal and as the ration of ^3HTdR incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (Stimulation Index).
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: “Skin Sensitisation: Local Lymph Node Assay”
- Criteria used to consider a positive response: The test material will be regarded as a sensitiser if at least one concentration of the test material results in a threefold or greater increase in ^3HTdR incorporation compared to control values.
TREATMENT PREPARATION AND ADMINISTRATION:
The dorsal surface of both ears was epidermally treated (0.25 µL/ear). The concentrations were mixed thoroughly using a vortex mixer immediately prior to dosing. The application was repeated on days 2 and 3. On day 6 an injection of 250 µL phosphate buffered saline (PBS) containing 20 µCi of 3H-methyl thymidine (3H-TdR) was made into the tail vein of each experimental mouse. Five hours later, the draining Auricular lymph node of each ear was excised into PBS. The relative size of the nodes and surrounding area were recorded. The nodes were pooled for each animal in approximately 3mL PBS. A single cell suspension of lymph node cells (LNC) was prepared in PBS by gentle separation through stainless steel gauze. LNC were washed twice with an excess of PBS by centifugation at 200g for 10 minutes at 4C. To precipitate the DNA, the LNC were exposed to 5% trichloroacetic acid (TCA) at 4 C during the night. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Positive control results:
- Concentration v/v in acetone/olive oil 4:1: 5, 10 and 25%
Stimulation Index:5%- 1.7; 10% 2.8; 25% 3.6
Result: Positive - Key result
- Parameter:
- SI
- Value:
- 23.6
- Test group / Remarks:
- 5%
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Concentration (% v/v) Mean dpm/Animal (Standard Deviation) Vehicle 504 (± 83) 25% - 7673 (±1172) 10% - 9188 (±540) 5% - 11871 (±2958)
- Key result
- Parameter:
- SI
- Value:
- 18.2
- Test group / Remarks:
- 10%
- Key result
- Parameter:
- SI
- Value:
- 15.2
- Test group / Remarks:
- 25%
- Interpretation of results:
- sensitising
- Conclusions:
- In a Local Lymph Node Assay in the Mouse, the substance initiated a Stimulation Index of greater than 3 at concentrations of 5, 10 and 25% and thus is considered to be a skin sensitiser under the conditions of the test.
- Executive summary:
In a Local Lymph Node Assay in the Mouse, conducted to Method B.42 of commission directive 440/2008 / OECD Guideline for the Testing of Chemicals No.429, the substance initiated a Stimulation Index of greater than 3 at concentrations of 5, 10 and 25% and thus is considered to be a skin sensitiser under the conditions of the test.
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Referenceopen allclose all
Individual Disintegrations per Minute and Stimulation Indices
% test substance |
Animal Number |
dpm/Animal a |
Mean dpm/Animal (Standard Deviation) |
Stimulation Index b |
Result |
Vehicle |
1-1 |
587 |
504 (+/-83) |
1.0 |
N/A |
1-2 |
790 |
||||
1-3 |
396 |
||||
1-4 |
330 |
||||
1-5 |
417 |
||||
5 |
2-1 |
21923 |
11871 (+/-2958) |
23.6 |
Positive |
2-2 |
14214 |
||||
2-3 |
6599 |
||||
2-4 |
11079 |
||||
2-5 |
5539 |
||||
10 |
3-1 |
7267 |
9188 (+/-540) |
18.2 |
Positive |
3-2 |
9319 |
||||
3-3 |
10093 |
||||
3-4 |
8956 |
||||
3-5 |
10305 |
||||
25 |
4-1 |
8765 |
7673 (+/-1172) |
15.2 |
Positive |
4-2 |
3752 |
||||
4-3 |
10686 |
||||
4-4 |
6631 |
||||
4-5 |
8533 |
Dpm = disintegrations per minutes
a = total number of lymph nodes per animals is 2
b = Stimulation Index of 3.0 or greater indicates a positive result
Individual Bodyweights and Bodyweight Changes
Animal Number |
Bodyweight (g) |
|||
Day 1 |
Day 6 |
|||
Vehicle |
1-1 |
27 |
25 |
|
1-2 |
26 |
23 |
||
1-3 |
28 |
27 |
||
1-4 |
26 |
25 |
||
1-5 |
25 |
24 |
||
5 |
2-1 |
29 |
19 |
|
2-2 |
27 |
22 |
||
2-3 |
25 |
21 |
||
2-4 |
27 |
22 |
||
2-5 |
27 |
23 |
||
10 |
3-1 |
26 |
24 |
|
3 -2 |
28 |
23 |
||
3 -3 |
27 |
24 |
||
3-4 |
29 |
25 |
||
3-5 |
25 |
22 |
||
25 |
4-1 |
28 |
22 |
|
4-2 |
26 |
23 |
||
4-3 |
29 |
25 |
||
4-4 |
25 |
20 |
||
4-5 |
25 |
20 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
In a key Local Lymph Node Assay in the Mouse, conducted in accordance with OECD 429 and EU Method B.42, the dorsal surface of both ears was epidermally treated (0.25 µL/ear). The concentrations were mixed thoroughly using a vortex mixer immediately prior to dosing. The application was repeated on days 2 and 3. On day 6 an injection of 250 µL phosphate buffered saline (PBS) containing 20 µCi of 3H-methyl thymidine (3H-TdR) was made into the tail vein of each experimental mouse. Five hours later, the draining Auricular lymph node of each ear was excised into PBS. The relative size of the nodes and surrounding area were recorded. The nodes were pooled for each animal in approximately 3mL PBS. A single cell suspension of lymph node cells (LNC) was prepared in PBS by gentle separation through stainless steel gauze. LNC were washed twice with an excess of PBS by centifugation at 200g for 10 minutes at 4C. To precipitate the DNA, the LNC were exposed to 5% trichloroacetic acid (TCA) at 4 C during the night. The substance initiated a Stimulation Index of greater than 3 at concentrations of 5, 10 and 25% and thus is considered to be a skin sensitizer under the conditions of the test.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Since the test item concentration (EC3 value) resulting in a stimulation index > 3 was higher than 2 % in the Local Lymph Node Assay, classification as a skin sensitiser (category 1B) is appropriate under the criteria given by Regulation (EC) No 1272/2008 and subsequent amendments.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.